Abstract
The purpose of this study was to systematically review the literature for studies that have investigated possible differences in the prevalence of subclinical Cushing’s syndrome (SCS) and related clinical implications between patients with unilateral (UAI) and bilateral adrenal incidentalomas (BAI) and to meta-analyze the best evidence available. Electronic databases PubMed and EMBASE were systematically searched. Main study outcome was the prevalence of SCS in patients with UAI and BAI. Secondary outcomes were the prevalence of obesity, diabetes, glucose intolerance, hypertension, dyslipidemia, and osteoporosis in patients with UAI and BAI. Risk differences (RD) or mean differences (MD) and 95 % confidence intervals (CIs) were calculated. Meta-analysis was conducted using Review Manager (RevMan 5.3). Six studies were included in the meta-analysis involving in total 1239 patients, 968 with UAI, and 271 with BAI. Patients with UAI had lower prevalence of SCS compared with those with BAI [RD (95 % CI) −0.13 (−0.22 to −0.05), I 2 = 42 %]. The mass diameter of UAI did not differ from BAI (the size of the largest lesion) [MD (95 % CI) −0.45 (−1.09 to 0.19), I 2 = 91 %]. The prevalence of obesity [MD (95 % CI) 0.42 (−0.53 to 1.37), I 2 = 4 %], diabetes [RD (95 % CI) −0.04 (−0.11 to 0.04), I 2 = 0 %], hypertension [RD (95 % CI) 0.00 (−0.18 to 0.18), I 2 = 75 %], and dyslipidemia [RD (95 % CI) −0.02 (−0.16 to 0.13), I 2 = 50 %] did not differ between UAI and BAI. The present meta-analysis provided evidence that patients with BAI present a higher prevalence of SCS compared to patients with UAI.
Similar content being viewed by others
References
R.T. Kloos, M.D. Gross, I.R. Francis, M. Korobkin, B. Shapiro, Incidentally discovered adrenal masses. Endocr. Rev. 16, 460–484 (1995)
C. Davenport, A. Liew, B. Doherty, H.H. Win, H. Misran, S. Hanna, D. Kealy, F. Al-Nooh, A. Agha, C.J. Thompson, M. Lee, D. Smith, The prevalence of adrenal incidentaloma in routine clinical practice. Endocrine 40, 80–83 (2011)
S. Bovio, A. Cataldi, G. Reimondo, P. Sperone, S. Novello, A. Berruti, P. Borasio, C. Fava, L. Dogliotti, G.V. Scagliotti, A. Angeli, M. Terzolo, Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J. Endocrinol. Invest. 29, 298–302 (2006)
J.H. Song, F.S. Chaudhry, W.W. Mayo-Smith, The incidental adrenal mass on CT: prevalence of adrenal disease in 1,029 consecutive adrenal masses in patients with no known malignancy. AJR Am. J. Roentgenol. 190, 1163–1168 (2008)
L. Barzon, N. Sonino, F. Fallo, G. Palu, M. Boscaro, Prevalence and natural history of adrenal incidentalomas. Eur. J. Endocrinol. 146, 61–66 (2002)
M. Terzolo, S. Bovio, G. Reimondo, A. Pia, G. Osella, G. Borretta, A. Angeli, Subclinical Cushing’s syndrome in adrenal incidentalomas. Endocrinol. Metab. Clin. N. Am. 34, 423–439 (2005)
M. Reincke, J. Nieke, G.P. Krestin, W. Saeger, B. Allolio, W. Winkelmann, Preclinical Cushing’s syndrome in “adrenal incidentalomas”: comparison with adrenal Cushing’s syndrome. J. Clin. Endocrinol. Metab. 75, 826–832 (1992)
R. Rossi, L. Tauchmanova, A. Luciano, M. Di Martino, C. Battista, L. Del Viscovo, V. Nuzzo, G. Lombardi, Subclinical Cushing’s syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J. Clin. Endocrinol. Metab. 85, 1440–1448 (2000)
F. Mantero, M. Terzolo, G. Arnaldi, G. Osella, A.M. Masini, A. Ali, M. Giovagnetti, G. Opocher, A.A. Angeli, Survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of the Italian Society of Endocrinology. J. Clin. Endocrinol. Metab. 85, 637–644 (2000)
E. Vassilatou, A. Vryonidou, S. Michalopoulou, J. Manolis, J. Caratzas, C. Phenekos, I. Tzavara, Hormonal activity of adrenal incidentalomas—results from a long term follow-up study. Clin. Endocrinol. (Oxf.) 70, 674–679 (2009)
D. Aron, M. Terzolo, T.J. Cawood, Adrenal incidentalomas. Best Pract. Res. Clin. Endocrinol. Metab. 26, 69–82 (2012)
R. Giordano, F. Guaraldi, R. Berardelli, I. Karamouzis, V. D’Angelo, E. Marinazzo, A. Picu, E. Ghigo, E. Arvat, Glucose metabolism in patients with subclinical Cushing’s syndrome. Endocrine 41, 415–423 (2012)
K. Duan, H.K. Gomez, O. Mete, Clinicopathological correlates of adrenal Cushing’s syndrome. J. Clin. Pathol. 68, 175–186 (2015)
A. Patocs, M. Toth, C. Barta, M. Sasvari-Szekely, I. Varga, N. Szucs, C. Jakab, E. Glaz, K. Racz, Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas. Eur. J. Endocrinol. 147, 349–355 (2002)
D.A. Vassiliadi, G. Ntali, E. Vicha, S. Tsagarakis, High prevalence of subclinical hypercortisolism in patients with bilateral adrenal incidentalomas: a challenge to management. Clin. Endocrinol. (Oxf.) 74, 438–444 (2011)
I. Androulakis, G. Kaltsas, A. Markou, E. Tseniklidi, P. Kafritsa, T. Pappa, L. Papanastasiou, G. Piaditis, The functional status of incidentally discovered bilateral adrenal lesions. Clin. Endocrinol. (Oxf.) 75, 44–49 (2011)
H. Olsen, E. Nordensrom, A. Bergenfelz, U. Nyman, S. Valdemarsson, E. Palmqvist, Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden. Endocrine 42, 164–173 (2012)
V. Morelli, S. Palmieri, A.S. Salcuni, C. Eller-Vainicher, E. Cairoli, V. Zhukouskaya, A. Scillitani, P. Beck-Peccoz, I. Chiodini, Bilateral and unilateral adrenal incidentalomas: biochemical and clinical characteristics. Eur. J. Endocrinol. 168, 235–241 (2013)
E. Vassilatou, A. Vryonidou, D. Ioannidis, S.A. Paschou, M. Panagou, I. Tzavara, Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications. Eur. J. Endocrinol. 171, 37–45 (2014)
M. Viswanathan, N.D. Berkman, D.M. Dryden, L. Hartling, Assessing Risk of Bias and Confounding in Observational Studies of Interventions or Exposures: Further Development of the RTI Item Bank. Methods Research Report (Prepared by RTI–UNC Evidence-based Practice Center under Contract No. 290-2007-10056-I). AHRQ Publication No. 13-EHC106-EF (Agency for Healthcare Research and Quality, Rockville, 2013)
R. DerSimonian, N. Laird, Meta-analysis in clinical trials. Control Clin. Trials 7, 177–188 (1986)
M. Egger, G. Davey Smith, D. Altman, Systematic Reviews in Health Care: Meta-analysis in Context (BMJ Publishing Group, London, 2001)
D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6, e1000097 (2009)
S. Yener, H. Yilmaz, T. Demir, M. Secil, A. Comlekci, DHEAS for the prediction of subclinical Cushing’s syndrome: perplexing or advantageous? Endocrine 48, 669–676 (2015)
W.F. Young Jr, H. du Plessis, G.B. Thompson, C.S. Grant, D.R. Farley, M.L. Richards, D. Erickson, A. Vella, A.W. Stanson, J.A. Carney, C.F. Abboud, P.C. Carpenter, The clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal masses. World J. Surg. 32, 856–862 (2008)
M. Terzolo, G. Osella, A. Ali, G. Borretta, F. Cesario, P. Paccotti, A. Angeli, Subclinical Cushing’s syndrome in adrenal incidentaloma. Clin. Endocrinol. (Oxf.) 48, 89–97 (1998)
G.P. Bernini, A. Moretti, C. Oriandini, M. Bardini, C. Taurino, A. Salvetti, Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas. Br. J. Cancer 92, 1104–1109 (2005)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Paschou, S.A., Kandaraki, E., Dimitropoulou, F. et al. Subclinical Cushing’s syndrome in patients with bilateral compared to unilateral adrenal incidentalomas: a systematic review and meta-analysis. Endocrine 51, 225–235 (2016). https://doi.org/10.1007/s12020-015-0776-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-015-0776-6